Tenax Therapeutics, Inc.
TENX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000034956
In the last 90 days, Tenax Therapeutics, Inc. insiders filed 6 open-market purchases and 0 sales; 111 institutions reported holding it in 13F filings for Q2 2026, worth $441.4M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Tenax Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +3 vs. Q1 2025
- Shares held
- 2.23M
- +225.6K (+11.2%) vs. Q1 2025
- Total value
- $12.9M
- −$184.3K (−1.4%) vs. Q1 2025
- New holders
- 3
- 6 more added
- Sold out
- 0
- 4 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TENX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $441.4M |
| Q1 2026 | 81 | $341.0M |
| Q4 2025 | 49 | $85.9M |
| Q3 2025 | 34 | $35.9M |
| Q2 2025 | 26 | $12.9M |
| Q1 2025 | 23 | $13.1M |
| Q4 2024 | 21 | $8.43M |
| Q3 2024 | 19 | $4.25M |
| Q2 2024 | 11 | $57.2K |
| Q1 2024 | 9 | $30.5K |
| Q4 2023 | 17 | $367.6K |
| Q3 2023 | 16 | $184.8K |
| Q2 2023 | 15 | $119.2K |
| Q1 2023 | 13 | $230.6K |
| Q4 2022 | 19 | $691.8K |
| Q3 2022 | 29 | $1.24M |
| Q2 2022 | 25 | $2.08M |
| Q1 2022 | 25 | $6.54M |
| Q4 2021 | 28 | $8.38M |
| Q3 2021 | 25 | $13.6M |
| Q2 2021 | 25 | $7.32M |
| Q1 2021 | 26 | $7.21M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Tenax Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Union Bancaire Privee, UBP SA | 1 | $5 | 0.00% | 00.0% | Unchanged |
| UMA Financial Services, Inc. | 1 | $6 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 1 | $6 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 1 | $6 | 0.00% | +1 | New |
| Barclays PLC | 11 | $63 | 0.00% | +11 | New |
| UBS Group AG | 14 | $81 | 0.00% | −2,879−99.5% | Reduced |
| Bank of America Corp | 249 | $1.43K | 0.00% | +20+8.7% | Added |
| BlackRock, Inc. | 300 | $1.73K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,249 | $7.19K | 0.00% | +1,057+550.5% | Added |
| Raymond James Financial Inc | 1,503 | $8.66K | 0.00% | +1,503 | New |
| Citadel Advisors LLC | 10,345 | $60.4K | 0.00% | −12,796−55.3% | Reduced |
| Dimensional Fund Advisors LP | 15,930 | $93.0K | 0.00% | −3,313−17.2% | Reduced |
| Vanguard Group Inc | 22,287 | $130.2K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 34,236 | $199.9K | 0.00% | +895+2.7% | Added |
| Vestal Point Capital, LP | 53,439 | $307.8K | 0.02% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 83,333 | $480.0K | 0.00% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 83,333 | $480.0K | 0.48% | 00.0% | Unchanged |
| VR Adviser, LLC | 98,564 | $567.7K | 0.04% | −109,769−52.7% | Reduced |
| ADAR1 Capital Management, LLC | 155,557 | $896.0K | 0.15% | +86,816+126.3% | Added |
| Integral Health Asset Management, LLC | 167,000 | $961.9K | 0.09% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 166,666 | $978.3K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 178,010 | $1.03M | 0.00% | +56,916+47.0% | Added |
| Vivo Capital, LLC | 208,333 | $1.20M | 0.12% | 00.0% | Unchanged |
| Millennium Management LLC | 233,714 | $1.36M | 0.00% | +207,088+777.8% | Added |
| BVF Inc | 339,549 | $1.98M | 0.07% | 00.0% | Unchanged |
| RTW Investments, LP | 378,346 | $2.18M | 0.03% | 00.0% | Unchanged |